Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Amina Džidić-Krivić, Jasna Kusturica, Emina Karahmet Sher, Nejra Selak, Nejra Osmančević, Esma Karahmet Farhat & Farooq Sher. (2023) Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metabolism Reviews 55:1-2, pages 126-139.
Read now
Read now
Articles from other publishers (43)
Yi Wu, Feng Zhang, Dan Kuang, Dan Li, Jiai Yan, Ju Yang, Qinyue Wang, Yingyu Wang, Jing Sun, Yiran Liu, Yanping Xia & Hong Cao. (2024) Efficacy of botanical lozenges in the treatment of chronic pharyngitis: a randomized controlled trial. Frontiers in Pharmacology 15.
Crossref
Crossref
Di Yang, Xiaoxu Cheng, Meiling Fan, Dong Xie, Zhiqiang Liu, Fei Zheng, Yulin Dai, Zifeng Pi & Hao Yue. (2024) Regulation of polysaccharide in Wu‐tou decoction on intestinal microflora and pharmacokinetics of small molecular compounds in AIA rats. Chinese Medicine 19:1.
Crossref
Crossref
Mark Ashton, Paul W. Groundwater, Sophie Stocker & Adam Todd. 2024. An Integrated Guide to Human Drug Metabolism. An Integrated Guide to Human Drug Metabolism
197
212
.
Bing Ma, Samuel J. Gavzy, Michael France, Yang Song, Hnin Wai Lwin, Allison Kensiski, Vikas Saxena, Wenji Piao, Ram Lakhan, Jegan Iyyathurai, Lushen Li, Christina Paluskievicz, Long Wu, Marina WillsonShirkey, Emmanuel F. Mongodin, Valeria R. Mas & Jonathan S. Bromberg. (2023) Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment. BMC Microbiology 23:1.
Crossref
Crossref
Ying Dong, Xiao Li, Yicheng Zhao, Xueyang Ren, Yuan Zheng, Ruolan Song, Xiangjian Zhong, Dongjie Shan, Fang Lv, Qingyue Deng, Xianxian Li, Yingyu He, Keyan Chai, Xiuhuan Wang & Gaimei She. (2023) Biotransformation and metabolism of three methyl salicylate glycosides by gut microbiota in vitro. Journal of Pharmaceutical and Biomedical Analysis 233, pages 115474.
Crossref
Crossref
Chen Liu, Jing Jin & Ivonne M.C.M. Rietjens. (2023) New approach methodologies (NAMs) to study microbiome–host interactions. Current Opinion in Toxicology 35, pages 100406.
Crossref
Crossref
Hua Liu, Yanmiao Fan, Jie Zhong, Michael Malkoch, Zhengwei Cai & Zhengting Wang. (2023) Advance in oral delivery of living material. Biomedical Technology 3, pages 26-39.
Crossref
Crossref
Nicholas A. Meanwell. (2023) The pyridazine heterocycle in molecular recognition and drug discovery. Medicinal Chemistry Research 32:9, pages 1853-1921.
Crossref
Crossref
Sara Mousa, Muhammad Sarfraz & Walaa K. Mousa. (2023) The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine. Metabolites 13:5, pages 674.
Crossref
Crossref
Benneth Ben-Azu, Elisabetta C. del Re, Jared VanderZwaag, Micaël Carrier, Matcheri Keshavan, Mohammadparsa Khakpour & Marie-Ève Tremblay. (2023) Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia. Frontiers in Cellular Neuroscience 17.
Crossref
Crossref
Yanbin Chu & Rong Wang. (2023) Present situation of rational drug use in plateau area. Frigid Zone Medicine 3:2, pages 92-96.
Crossref
Crossref
Xiaoling Zhang, Qin Miao, Chengxue Pan, Jia Yin, Leli Wang, Lingbo Qu, Yulong Yin & Yongjun Wei. (2023) Research advances in probiotic fermentation of Chinese herbal medicines. iMeta 2:2.
Crossref
Crossref
Xiaohui Li, Huan Wei, Jiachen Qi, Ke Ma, Yucheng Luo & Lixing Weng. (2023) Interactions of Nanomaterials with Gut Microbiota and Their Applications in Cancer Therapy. Sensors 23:9, pages 4428.
Crossref
Crossref
Siyu Song, Lu Ding, Guangwen Liu, Tian Chen, Meiru Zhao, Xueyan Li, Min Li, Hongyu Qi, Jinjin Chen, Ziyuan Wang, Ying Wang, Jing Ma, Qi Wang, Xiangyan Li & Zeyu Wang. (2023) The protective effects of baicalin for respiratory diseases: an update and future perspectives. Frontiers in Pharmacology 14.
Crossref
Crossref
Hao Zhang, Hong Zhang & Qin Jiang. (2023) Progress in research of gut microbiota in colorectal cancer. World Chinese Journal of Digestology 31:4, pages 138-142.
Crossref
Crossref
Ruxiao Hu. (2023) Grifola frondosa may play an anti-obesity role by affecting intestinal microbiota to increase the production of short-chain fatty acids. Frontiers in Endocrinology 13.
Crossref
Crossref
Aneela Gulnaz, Ji-Eun Chang, Han-Joo Maeng, Kwang-Hee Shin, Kyeong-Ryoon Lee & Yoon-Jee Chae. (2022) A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota. Journal of Pharmaceutical Investigation 53:1, pages 73-92.
Crossref
Crossref
Tao Wang, Xin-Lei Tian, Xue-Bin Xu, Hui Li, Ye Tian, Yi-Han Ma, Xiao-Fei Li, Na Li, Ting-Ting Zhang, Yu-Di Sheng, Qian-Xi Tang, Lei Zhang, Chun-Feng Wang, Shahrood Ahmed Siddiquid, Li-Xia Wang, Xiao-Feng Shan, Ai-Dong Qian & Dong-Xing Zhang. (2022) Dietary supplementation of probiotics fermented Chinese herbal medicine Sanguisorba officinalis cultures enhanced immune response and disease resistance of crucian carp (Carassius auratus) against Aeromonas hydrophila. Fish & Shellfish Immunology 131, pages 682-696.
Crossref
Crossref
Eun-Ji Song, Na Rae Shin, Songhee Jeon, Young-Do Nam & Hojun Kim. (2022) Impact of the herbal medicine, Ephedra sinica stapf, on gut microbiota and body weight in a diet-induced obesity model. Frontiers in Pharmacology 13.
Crossref
Crossref
Yucui Zhao, Xinqin Zhong, Junyuan Yan, Congying Sun, Xin Zhao & Xiaoying Wang. (2022) Potential roles of gut microbes in biotransformation of natural products: An overview. Frontiers in Microbiology 13.
Crossref
Crossref
Le Liu, Yuping Bai, Lin Xiang, Wenbo Qi, Lei Gao, Xiaomei Li, Haiyuan Li, Bofang Wang & Hao Chen. (2022) Interaction between gut microbiota and tumour chemotherapy. Clinical and Translational Oncology 24:12, pages 2330-2341.
Crossref
Crossref
Shanshan Yang, Shaodong Hao, Qin Wang, Yanni Lou, Liqun Jia & Dongmei Chen. (2022) The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Lihong Fu, Yihan Qian, Zhi Shang, Xuehua Sun, Xiaoni Kong & Yueqiu Gao. (2022) Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: Emerging role of gut microbiota dysbiosis. Frontiers in Medicine 9.
Crossref
Crossref
Dan Li, Yujuan Li, Shengjie Yang, Jing Lu, Xiao Jin & Min Wu. (2022) Diet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics. Biomedicine & Pharmacotherapy 153, pages 113290.
Crossref
Crossref
Christina Kostantini, Sumit Arora, Erik Söderlind, Jens Ceulemans, Christos Reppas & Maria Vertzoni. (2022) Usefulness of Optimized Human Fecal Material in Simulating the Bacterial Degradation of Sulindac and Sulfinpyrazone in the Lower Intestine. Molecular Pharmaceutics 19:7, pages 2542-2548.
Crossref
Crossref
Li Wang, Chak Kwong Cheng, Min Yi, Kathy O. Lui & Yu Huang. (2022) Targeting endothelial dysfunction and inflammation. Journal of Molecular and Cellular Cardiology 168, pages 58-67.
Crossref
Crossref
Adrián Hernández-Mendoza, Aarón F. González-Córdova & Marcel Martínez-Porchas. (2022) Influence of Probiotics on the Animal Gut Microbiota and Their Impact on the Bioavailability of Toxic Agents: An Opinion Paper. Frontiers in Nutrition 9.
Crossref
Crossref
Andrew P. Shoubridge, Jocelyn M. Choo, Alyce M. Martin, Damien J. Keating, Ma-Li Wong, Julio Licinio & Geraint B. Rogers. (2022) The gut microbiome and mental health: advances in research and emerging priorities. Molecular Psychiatry 27:4, pages 1908-1919.
Crossref
Crossref
Suqing Zheng, Lei Wang, Jun Xiong, Guang Liang, Yong Xu & Fu Lin. (2022) Consensus Prediction of Human Gut Microbiota-Mediated Metabolism Susceptibility for Small Molecules by Machine Learning, Structural Alerts, and Dietary Compounds-Based Average Similarity Methods. Journal of Chemical Information and Modeling 62:4, pages 1078-1099.
Crossref
Crossref
Abhinav Kanwal, Navjot Kanwar, Sanjay Bharati, Prateek Srivastava, Shailendra P. Singh & Salomon Amar. (2022) Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities. Biomedicines 10:2, pages 331.
Crossref
Crossref
Hui-Qing Chen, Jin-Yu Gong, Kai Xing, Mou-Ze Liu, Huan Ren & Jian-Quan Luo. (2022) Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment. Frontiers in Medicine 8.
Crossref
Crossref
Xin Zhou, Bowen Li, Mingming Guo, Wenchang Peng, Deping Wang, Qinglu Guo, Shuchao Wang, Dong Ming & Bin Zheng. (2022) Microneedle patch based on molecular motor as a spatio-temporal controllable dosing strategy of L-DOPA for Parkinson’s disease. Chemical Engineering Journal 427, pages 131555.
Crossref
Crossref
Ana Bačić & Mirjana Rajilić-Stojanović. 2022. Comprehensive Gut Microbiota. Comprehensive Gut Microbiota
1
12
.
Connor O'Farrell, Konstantinos Stamatopoulos, Mark Simmons & Hannah Batchelor. (2021) In vitro models to evaluate ingestible devices: Present status and current trends. Advanced Drug Delivery Reviews 178, pages 113924.
Crossref
Crossref
Bei Yue, Ruiyang Gao, Zhengtao Wang & Wei Dou. (2021) Microbiota-Host-Irinotecan Axis: A New Insight Toward Irinotecan Chemotherapy. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Julia Aresti-Sanz, Markus Schwalbe, Rob Pereira, Hjalmar Permentier & Sahar El Aidy. (2021) Stability of Methylphenidate under Various pH Conditions in the Presence or Absence of Gut Microbiota. Pharmaceuticals 14:8, pages 733.
Crossref
Crossref
Ming Tian, Xinmiao He, Yanzhong Feng, Wentao Wang, Heshu Chen, Ming Gong, Di Liu, Jihong Liu Clarke & André van Eerde. (2021) Pollution by Antibiotics and Antimicrobial Resistance in LiveStock and Poultry Manure in China, and Countermeasures. Antibiotics 10:5, pages 539.
Crossref
Crossref
Marilyn N. Martinez, Jonathan P. Mochel, Sibylle Neuhoff & Devendra Pade. (2021) Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics. The AAPS Journal 23:3.
Crossref
Crossref
Tingshuai Wang, Shaodong Huang, Cong Wu, Na Wang, Rongzhen Zhang, Minggang Wang & Dewen Mao. (2021) Intestinal Microbiota and Liver Diseases: Insights into Therapeutic Use of Traditional Chinese Medicine. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-13.
Crossref
Crossref
Mary V. Seeman. (2021) The gut microbiome and antipsychotic treatment response. Behavioural Brain Research 396, pages 112886.
Crossref
Crossref
Julia Shanu-Wilson, Liam EvansStephen WrigleyJonathan SteeleJames Atherton & Jason Boer. (2020) Biotransformation: Impact and Application of Metabolism in Drug Discovery. ACS Medicinal Chemistry Letters 11:11, pages 2087-2107.
Crossref
Crossref
Jielong Guo, Manwen Yin, Xue Han, Yilin You, Weidong Huang & Jicheng Zhan. (2020) The influence of oxygen on the metabolites of phenolic blueberry extract and the mouse microflora during in vitro fermentation. Food Research International 136, pages 109610.
Crossref
Crossref
wangtao Wang, Xin-Lei Tian, Xue-Bin Xu, Hui Li, Ye Tian, Yi-Han Ma, Xiao-Fei Li, Na Li, Ting-Ting Zhang, Yu-Di Sheng, Qian-Xi Tang, Lei Zhang, Chun-Feng Wang, Shahrood Ahmed Siddiquid, Li-Xia Wang, Xiaofeng Shan, Aidong Qian & DongXing Zhang. (2022) Dietary Supplementation of Probiotics Fermented Chinese Herbal Medicine Sanguisorba Officinalis Cultures Enhanced Immune Response and Disease Resistance of Crucian Carp (Carassius Auratus) Against Aeromonas Hydrophila. SSRN Electronic Journal.
Crossref
Crossref